ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bullishWuXi AppTec
21 Nov 2018 10:41

Wuxi Apptec 药明康德 IPO: Welcome to the A/H Universe

WuXi Apptec is set to be the newest A/H pair with its upcoming HK listing that is set to raise USD 1 billion. The A-share (603289 CH) recorded 15...

Share
18 Nov 2018 19:05

Smartkarma's Week in JP/KR: SoftbankCorp IPO, Toshiba, J-Banks, Wafers/Semi, Hanjin Kal, BioLogics

This past week featured 165 insights across the Smartkarma platform, with about 25% of them dealing with Japan or South Korea.  A list is below.By...

Logo
381 Views
Share
bullishSamsung C&T
15 Nov 2018 08:12

Samsung BioLogics Trade Suspension: Short Celltrion/Long Samsung C&T

The FSC said it had found intentionality behind BioLogics’ breach of accounting rules. Hence, the FSC pressed criminal charges against BioLogics...

Logo
470 Views
Share
14 Nov 2018 17:09

Samsung Biologics: A Temporary Suspension of Shares Trading

The Korean financial regulators announced a temporary suspension of shares trading for Samsung Biologics Co., (207940 KS) as of today, mainly due...

Logo
478 Views
Share
bullishSamsung C&T
13 Nov 2018 07:59

Samsung C&T Stub Trade: Holdco Discount Still at a Historic Low Despite BioLogics Misfortune

Samsung C&T (028260 KS) holdco discount is still at a historic low despite Samsung Biologics Co., (207940 KS)' recent misfortune....

Logo
392 Views
Share
x